Hopfner Robert Lorne
SEC insider (Form 3/4/5 filer). CIK 0001551966. Director at Rallybio Corp (RLYB) and 2 other issuers. 12 reported Form 4/5 transactions since Sep 2024; latest on Oct 12, 2026. Located in EAST BERLIN, CT.
Companies Hopfner Robert Lorne has filed insider reports for
- Rallybio Corp (RLYB): Director
- Evommune, Inc. (EVMN): Director, 10% Owner
- Inozyme Pharma, Inc. (INZY): Director
Hopfner Robert Lorne
CIK: 0001551966
Transaction Breakdown
Open Market Buys (P)1 (8.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)3 (25.0%)
Derivative conversions
Awards (A)2 (16.7%)
Compensation grants
Other (G, F, J, C, D, …)6 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (12 total)
- Oct 12, 2026RLYB
Rallybio Corp
ExerciseDirect3.6K shares at avg. $2.38$8K - Oct 12, 2026RLYB
Rallybio Corp
ExerciseDirect2.1K shares at avg. $15.28$32K - Oct 12, 2026RLYB
Rallybio Corp
ExerciseDirect9.2K shares at avg. $7.60$70K - Dec 19, 2025EVMN
Evommune, Inc.
PurchaseIndirect1K shares at avg. $17.35$17K - Nov 7, 2025EVMN
Evommune, Inc.
ConversionIndirect3K shares- - Nov 7, 2025EVMN
Evommune, Inc.
ConversionIndirect1.4M shares- - Nov 7, 2025EVMN
Evommune, Inc.
ConversionIndirect1.6M shares- - Nov 7, 2025EVMN
Evommune, Inc.
ConversionIndirect294.5K shares- - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender OfferIndirect1.6M shares at avg. $4.00$6.3M - Jul 1, 2025INZY
Inozyme Pharma, Inc.
Tender OfferIndirect2.9M shares at avg. $4.00$11.7M
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 12, 2026 |  RLYB Rallybio Corp | Exercise | 3,562 | $2.38 | $8,478 | Direct |
| Oct 12, 2026 | RLYB Rallybio Corp | Exercise | 2,062 | $15.28 | $31,507 | Direct |
| Oct 12, 2026 | RLYB Rallybio Corp | Exercise | 9,196 | $7.60 | $69,890 | Direct |
| Dec 19, 2025 |  EVMN Evommune, Inc. | Purchase | 1,000 | $17.35 | $17,350 | Indirect |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion | 3,026 | - | - | Indirect |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion | 1,441,032 | - | - | Indirect |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion | 1,632,441 | - | - | Indirect |
| Nov 7, 2025 | EVMN Evommune, Inc. | Conversion | 294,502 | - | - | Indirect |
| Jul 1, 2025 |  INZY Inozyme Pharma, Inc. | Tender Offer | 1,571,741 | $4.00 | $6,286,964 | Indirect |
| Jul 1, 2025 | INZY Inozyme Pharma, Inc. | Tender Offer | 2,923,110 | $4.00 | $11,692,440 | Indirect |
1-10 of 12 transactions